Literature DB >> 23752412

Amgen announces oncolytic virus shrinks tumors.

Cormac Sheridan.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23752412     DOI: 10.1038/nbt0613-471

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  5 in total

1.  Amgen spikes interest in live virus vaccines for hard-to-treat cancers.

Authors:  Charlie Schmidt
Journal:  Nat Biotechnol       Date:  2011-04       Impact factor: 54.908

2.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

Authors:  Suzanne L Topalian; F Stephen Hodi; Julie R Brahmer; Scott N Gettinger; David C Smith; David F McDermott; John D Powderly; Richard D Carvajal; Jeffrey A Sosman; Michael B Atkins; Philip D Leming; David R Spigel; Scott J Antonia; Leora Horn; Charles G Drake; Drew M Pardoll; Lieping Chen; William H Sharfman; Robert A Anders; Janis M Taube; Tracee L McMiller; Haiying Xu; Alan J Korman; Maria Jure-Kunkel; Shruti Agrawal; Daniel McDonald; Georgia D Kollia; Ashok Gupta; Jon M Wigginton; Mario Sznol
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

3.  Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma.

Authors:  Neil N Senzer; Howard L Kaufman; Thomas Amatruda; Mike Nemunaitis; Tony Reid; Gregory Daniels; Rene Gonzalez; John Glaspy; Eric Whitman; Kevin Harrington; Howard Goldsweig; Tracey Marshall; Colin Love; Robert Coffin; John J Nemunaitis
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544

Review 4.  Oncolytic virotherapy.

Authors:  Stephen J Russell; Kah-Whye Peng; John C Bell
Journal:  Nat Biotechnol       Date:  2012-07-10       Impact factor: 54.908

5.  Directed evolution generates a novel oncolytic virus for the treatment of colon cancer.

Authors:  Irene Kuhn; Paul Harden; Maxine Bauzon; Cecile Chartier; Julie Nye; Steve Thorne; Tony Reid; Shaoheng Ni; Andre Lieber; Kerry Fisher; Len Seymour; Gabor M Rubanyi; Richard N Harkins; Terry W Hermiston
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

  5 in total
  11 in total

1.  Panorama from the oncolytic virotherapy summit.

Authors:  Jonathan G Pol; Monique Marguerie; Rozanne Arulanandam; John C Bell; Brian D Lichty
Journal:  Mol Ther       Date:  2013-10       Impact factor: 11.454

Review 2.  Top 10 cardiovascular therapies and interventions for the next decade.

Authors:  Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2014-09-30       Impact factor: 32.419

3.  A novel oncolytic herpes simplex virus type 2 has potent anti-tumor activity.

Authors:  Qian Zhao; Wen Zhang; Zhifeng Ning; Xiufen Zhuang; Haizhen Lu; Jing Liang; Jie Li; Yu Zhang; Ying Dong; Youhui Zhang; Shuren Zhang; Shangmei Liu; Binlei Liu
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

4.  The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon.

Authors:  Wesley A Grimm; Jeannette S Messer; Stephen F Murphy; Thomas Nero; James P Lodolce; Christopher R Weber; Mark F Logsdon; Sarah Bartulis; Brooke E Sylvester; Amanda Springer; Urszula Dougherty; Timothy B Niewold; Sonia S Kupfer; Nathan Ellis; Dezheng Huo; Marc Bissonnette; David L Boone
Journal:  Gut       Date:  2015-02-02       Impact factor: 23.059

Review 5.  Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?

Authors:  Nicholas L Denton; Chun-Yu Chen; Thomas R Scott; Timothy P Cripe
Journal:  Biomedicines       Date:  2016-07-07

6.  Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study.

Authors:  Ravi N Samy; Brian R Earl; Noga Lipschitz; Ivy Schweinzger; Mark Currier; Timothy Cripe
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-10-15

7.  Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity.

Authors:  Jennifer L Leddon; Chun-Yu Chen; Mark A Currier; Pin-Yi Wang; Francesca A Jung; Nicholas L Denton; Kevin M Cripe; Kellie B Haworth; Michael A Arnold; Amy C Gross; Timothy D Eubank; William F Goins; Joseph C Glorioso; Justus B Cohen; Paola Grandi; David A Hildeman; Timothy P Cripe
Journal:  Mol Ther Oncolytics       Date:  2015-01-21       Impact factor: 7.200

Review 8.  Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications.

Authors:  Hanni Uusi-Kerttula; Sarah Hulin-Curtis; James Davies; Alan L Parker
Journal:  Viruses       Date:  2015-11-24       Impact factor: 5.048

Review 9.  Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs.

Authors:  Lynne Braidwood; Sheila V Graham; Alex Graham; Joe Conner
Journal:  Oncolytic Virother       Date:  2013-12-04

Review 10.  Therapeutic potential of oncolytic Newcastle disease virus: a critical review.

Authors:  Shay Tayeb; Zichria Zakay-Rones; Amos Panet
Journal:  Oncolytic Virother       Date:  2015-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.